The real-world risk score for hepatocellular carcinoma (RWS-HCC), developed in Singapore in 2020, incorporates age, sex, cirrhosis, diabetes, platelet count, and alpha-fetoprotein (AFP), all of which are routinely available clinical variables. This evidence concerns the gene AFP and Cirrhosis.